157 related articles for article (PubMed ID: 21081865)
1. The role of nodal staging in breast cancer. Past, present and future.
Hirche C; Mohr Z; Kneif S; Hünerbein M
Minerva Chir; 2010 Oct; 65(5):537-46. PubMed ID: 21081865
[TBL] [Abstract][Full Text] [Related]
2. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
3. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
4. Erratum to: Axillary recurrence rate following negative sentinel node biopsy for invasive breast cancer: long-term follow-up.
Kiluk JV; Ly QP; Santillan AA; Meade T; Ramos D; Reintgen DS; Dessureault S; Davis M; Shamehdi C; Cox CE
Ann Surg Oncol; 2010 Feb; 17(2):552-7. PubMed ID: 19957043
[TBL] [Abstract][Full Text] [Related]
5. Clinical applications of sentinel lymph-node biopsy for the staging and treatment of solid neoplasms.
Gipponi M
Minerva Chir; 2005 Aug; 60(4):217-33. PubMed ID: 16166921
[TBL] [Abstract][Full Text] [Related]
6. Axillary management after sentinel lymph node biopsy in breast cancer patients.
Rivers A; Hansen N
Surg Clin North Am; 2007 Apr; 87(2):365-77, ix. PubMed ID: 17498532
[TBL] [Abstract][Full Text] [Related]
7. A prospective evaluation of positron emission tomography scanning, sentinel lymph node biopsy, and standard axillary dissection for axillary staging in patients with early stage breast cancer.
Lovrics PJ; Chen V; Coates G; Cornacchi SD; Goldsmith CH; Law C; Levine MN; Sanders K; Tandan VR
Ann Surg Oncol; 2004 Sep; 11(9):846-53. PubMed ID: 15313737
[TBL] [Abstract][Full Text] [Related]
8. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients.
Pendas S; Dauway E; Cox CE; Giuliano R; Ku NN; Schreiber RH; Reintgen DS
Am Surg; 1999 Jun; 65(6):500-5; discussion 505-6. PubMed ID: 10366202
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
[TBL] [Abstract][Full Text] [Related]
10. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
[TBL] [Abstract][Full Text] [Related]
11. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
12. [The role of sentinel node biopsy in breast cancer surgery].
Stańczyk M; Dziekiewicz M; Maruszyński M; Olszewski WL
Pol Merkur Lekarski; 2005 Aug; 19(110):245-8. PubMed ID: 16245445
[TBL] [Abstract][Full Text] [Related]
13. [Efficiency of lymphatic mapping by intradermal injection of vital blue dye for sentinel node identification in T1-2 N0-1 M0 stage breast cancer patients].
Kokhreidze I; Nemsadze G; Gersamia G; Dzagnidze G; Janjalia M
Georgian Med News; 2005 Apr; (121):7-10. PubMed ID: 15908713
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy. Preferred method of axillary staging for breast cancer.
Tuttle TM
Minerva Ginecol; 2005 Jun; 57(3):293-303. PubMed ID: 16166937
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph-node biopsy compared to axillary lymph-node dissection for axillary staging in breast cancer patients.
Schrenk P; Shamiyeh A; Wayand W
Eur J Surg Oncol; 2001 Jun; 27(4):378-82. PubMed ID: 11417984
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy as the new standard of care in the surgical treatment for breast cancer.
Ferrari A; Rovera F; Dionigi P; Limonta G; Marelli M; Besana Ciani I; Bianchi V; Vanoli C; Dionigi R
Expert Rev Anticancer Ther; 2006 Oct; 6(10):1503-15. PubMed ID: 17069533
[TBL] [Abstract][Full Text] [Related]
17. Current status of sentinel lymph node biopsy in early breast cancer.
Jatoi I
Int J Fertil Womens Med; 2004; 49(5):215-21. PubMed ID: 15633478
[TBL] [Abstract][Full Text] [Related]
18. [The role of intraoperative gamma-probe-guided sentinel lymph node biopsy in the treatment of malignant melanoma and breast cancer].
Péley G; Sinkovics I; Liszkay G; Tóth J; Péter I; Farkas E; Téglás M; Hrívó A; Füzy M; Gilde K; Köves I
Orv Hetil; 1999 Oct; 140(42):2331-8. PubMed ID: 10560260
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy examination for breast cancer patients with clinically negative axillary lymph nodes after neoadjuvant chemotherapy.
Kinoshita T; Takasugi M; Iwamoto E; Akashi-Tanaka S; Fukutomi T; Terui S
Am J Surg; 2006 Feb; 191(2):225-9. PubMed ID: 16442950
[TBL] [Abstract][Full Text] [Related]
20. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group.
Husted Madsen A; Haugaard K; Soerensen J; Bokmand S; Friis E; Holtveg H; Peter Garne J; Horby J; Christiansen P
Breast; 2008 Apr; 17(2):138-47. PubMed ID: 17928226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
